References:
1 Taddio et al, CMAJ 2005; 172(13) 1691-1695
2 Koh et al, Pediatric Anesthesia 2004, 14; 977-982
3 Kleiber et al, Pediatrics vol 100, No 4, October 2002
4 Luhman et al, Pediatics, vol 113, No 3, March 2004
5 Summary of Product Characteristics
6 Nestor, Journal of drugs in Dermatology, July /August 2006, vol 5, issue
7 Taddio et al, The Annals of Pharmacology, 2002 April, vol 36
8 Mezei, Drug Permeation Enhancement, 1994, 171-98
9 MHRA LMX4 Lidocaine 4% w/w cream UK PAR
10 Data on file